Pfizer In Divestiture Talks Over $68B Wyeth Merger
Pfizer Inc. may be required to divest parts of its animal health businesses before regulators approve its $68 billion acquisition of Wyeth Inc., a deal detractors claim creates problematic overlaps in...To view the full article, register now.
Already a subscriber? Click here to view full article